PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells-Reference-Cited by-同舟云学术

PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells

Published:2021-08-07 Issue:11 Volume:36 Page:2291-2301
ISSN:1520-4081
Container-title:Environmental Toxicology
language:en
Short-container-title:Environmental Toxicology

Author:

Chen Hao¹,Wei Lining²,Luo Min³,Wang Xiangping³,Zhan Yongzi³,Mao Yan³,Huang Changjie³^ORCID,Li Jianmin⁴,Lu Heming¹^ORCID

Affiliation:

1. Department of Radiation Oncology The People's Hospital of Guangxi Zhuang Autonomous Region Nanning China

2. Department of Endoscopy Guangxi Medical University Affiliated Tumor Hospital Nanning China

3. Department of Oncology The Third Affiliated Hospital of Guangxi Medical University Nanning China

4. Department of Dermatology The Third Affiliated Hospital of Guangxi Medical University Nanning China

Funder

Natural Science Foundation of Guangxi Province

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Management, Monitoring, Policy and Law,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/tox.23342

Reference33 articles.

1. Management of Nasopharyngeal Carcinoma: Is Adjuvant Therapy Needed?

2. Concurrent chemoradiotherapy for loco‐regionally advanced nasopharyngeal carcinoma: treatment outcomes and prognostic factors;Kong M;Asian Pacific J Cancer Prevent,2018

3. Nasopharyngeal carcinoma

4. Epstein–Barr virus infection and nasopharyngeal carcinoma

5. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment;International Journal of Biological Macromolecules;2024-10

2. Screening of peptidyl arginine deiminase 4 inhibitors in traditional herbal medicines;Fitoterapia;2024-09

3. A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2024-05-10

4. Mitosis targeting in non-small lung cancer cells by inhibition of PAD4;Heliyon;2024-03

5. Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy;Pharmaceutics;2024-02-28